ADVANCES IN ANTI-EMETIC THERAPY

被引：66

作者：

BAKOWSKI, MT

机构：

来源：

CANCER TREATMENT REVIEWS | 1984年 / 11卷 / 03期

关键词：

D O I：

10.1016/0305-7372(84)90010-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：237 / 256

页数：20

共 67 条

[1]

AAPRO MS, 1983, ASCO, V2, P93

[2] ANTI-EMETIC EFFICACY AND TOXICITY OF NABILONE, A SYNTHETIC CANNABINOID, IN LUNG-CANCER CHEMOTHERAPY [J].

AHMEDZAI, S ;

CARLYLE, DL ;

CALDER, IT ;

MORAN, F .

BRITISH JOURNAL OF CANCER, 1983, 48 (05) :657-663

[3]

ALLAN S, 1984, ASCO, V3, P89

[4]

ARNOLD DJ, 1980, P AM ASSOC CANC RES, V21, P344

[5]

BAKER JJ, 1979, NEW ENGL J MED, V301, P728

[6]

BRUERA ED, 1983, CANCER TREAT REP, V67, P381

[7]

CHAN HSL, 1984, ASCO, V3, P108

[8] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J].

CHANG, AE ;

SHILING, DJ ;

STILLMAN, RC ;

GOLDBERG, NH ;

SEIPP, CA ;

BAROFSKY, I ;

SIMON, RM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) :819-824

[9]

CHANG AE, 1981, CANCER, V47, P1746

[10] ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].

COATES, A ;

ABRAHAM, S ;

KAYE, SB ;

SOWERBUTTS, T ;

FREWIN, C ;

FOX, RM ;

TATTERSALL, MHN .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208

← 1 2 3 4 5 6 7 →